改善印度患有血液性恶性瘤的老年人护理:克服挑战
Shivashankara1, Joyita Banerjee2, Ravi Mehrotra3
1Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Journal of geriatric oncology
|May 31, 2023
概括
印度 印度 印度
科学领域:
- 老年瘤学 老年瘤学
- 血液学的恶性瘤.
- 印度的公共卫生.
背景情况:
- 印度面临着快速增长的老年人口,预计到2030年将达到2亿.
- 家庭结构的转变会影响老年人的社会和心理支持.
- 血液性恶性瘤在60岁以上的人群中很常见,与衰老相关的问题使癌症治疗复杂化.
研究的目的:
- 讨论在印度照顾患有血液性恶性瘤的老年人的独特考虑.
- 检查未满足的需求,挑战和机会在这个人口的护理.
- 突出印度老年病评估和管理的不足利用情况.
主要方法:
- 对印度当前医疗保健环境的审查,涉及老年护理和血液恶性瘤.
- 分析将老年医疗原则纳入癌症护理中的挑战.
- 识别潜在的战略和改进机会.
主要成果:
- 在印度的医学教育和实践中,老年病的评估和管理尚未得到充分利用.
- 衰老障碍显著影响老年人的癌症护理.
- 需要具体的方法来将老年病学纳入印度患有血液恶性瘤的老年患者的护理.
结论:
- 在印度,改善患有血液性恶性瘤的老年人护理需要解决老年障碍.
- 将老年病评估纳入癌症护理中至关重要,但面临着重大挑战.
- 了解各种方法和当地的医疗保健背景对于有效实施至关重要.
更多相关视频
03:40Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
1.1K
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
544
相关概念视频
Bone Marrow Sampling and Transplants
364
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Overview of Hematopoiesis
4.2K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.2K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
